A phase I study to evaluate the safety, tolerability, and pharmacokinetics of HEC113995PA·H2O, a novel dual-acting serotonergic antidepressant, in healthy subjects - Wu, Xue; Wu, Qingqing; Ding, Qichen; Zhuang, Yulei; Luo, Lin; Zhang, Yingjun; Deng, Li; Jin, Chuanfei; Li, Xue; Huang, Zhangma; Qin, Haiping; Xin, Liang; et al. (Frontiers in Pharmacology, 2025)